CS175498B2 - - Google Patents
Info
- Publication number
- CS175498B2 CS175498B2 CS5170A CS517075A CS175498B2 CS 175498 B2 CS175498 B2 CS 175498B2 CS 5170 A CS5170 A CS 5170A CS 517075 A CS517075 A CS 517075A CS 175498 B2 CS175498 B2 CS 175498B2
- Authority
- CS
- Czechoslovakia
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2438020A DE2438020A1 (de) | 1974-08-05 | 1974-08-05 | 18-methyl-19-nor-20-keto-pregnane und verfahren zu ihrer herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS175498B2 true CS175498B2 (es) | 1977-05-31 |
Family
ID=5922668
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS5170A CS175498B2 (es) | 1974-08-05 | 1975-07-22 | |
| CS215A CS175500B2 (es) | 1974-08-05 | 1975-07-22 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS215A CS175500B2 (es) | 1974-08-05 | 1975-07-22 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4029777A (es) |
| JP (1) | JPS5141347A (es) |
| AT (1) | AT345998B (es) |
| BE (1) | BE832124A (es) |
| CA (1) | CA1037027A (es) |
| CH (1) | CH611910A5 (es) |
| CS (2) | CS175498B2 (es) |
| DD (1) | DD120192A5 (es) |
| DE (1) | DE2438020A1 (es) |
| DK (1) | DK136369C (es) |
| ES (1) | ES439720A1 (es) |
| FR (1) | FR2281123A1 (es) |
| GB (1) | GB1512258A (es) |
| HU (1) | HU171684B (es) |
| IL (1) | IL47770A (es) |
| NL (1) | NL7509326A (es) |
| SE (1) | SE404804B (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61144199A (ja) * | 1984-12-18 | 1986-07-01 | Pioneer Electronic Corp | スピ−カ用紙製振動部材の製造方法 |
| EP0382790A4 (en) * | 1987-08-25 | 1991-03-27 | Kelvin W. Gee | Compositions and methods for alleviating stress, anxiety and seizure activity |
| US5232917A (en) * | 1987-08-25 | 1993-08-03 | University Of Southern California | Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
| US5175154A (en) * | 1987-11-25 | 1992-12-29 | Research Corporation Technologies, Inc. | 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds |
| US9725481B2 (en) | 2013-04-17 | 2017-08-08 | Sage Therapeutics, Inc. | 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof |
| RS60420B1 (sr) | 2013-04-17 | 2020-07-31 | Sage Therapeutics Inc | 19-nor neuroaktivni steroidi za metode lečenja |
| AU2014256229B2 (en) | 2013-04-17 | 2018-10-04 | Sage Therapeutics, Inc. | 19-nor C3,3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof |
| WO2014169836A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor neuroactive steroids and methods of use thereof |
| PL3021852T3 (pl) | 2013-07-19 | 2021-07-05 | Sage Therapeutics, Inc. | Neuroaktywne steroidy, kompozycje i ich zastosowania |
| JP6466942B2 (ja) | 2013-08-23 | 2019-02-06 | セージ セラピューティクス， インコーポレイテッド | 向神経活性ステロイド、組成物、及びその使用 |
| US10246482B2 (en) | 2014-06-18 | 2019-04-02 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| WO2016061527A1 (en) | 2014-10-16 | 2016-04-21 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| HUE051488T2 (hu) | 2014-10-16 | 2021-03-01 | Sage Therapeutics Inc | Készítmények és eljárások központi idegrendszeri rendellenességek kezelésére |
| US10774108B2 (en) | 2014-11-27 | 2020-09-15 | Sage Therapeutics, Inc. | Compositions and methods for treating CNS disorders |
| PL3250210T3 (pl) | 2015-01-26 | 2021-07-26 | Sage Therapeutics, Inc. | Kompozycje i sposoby leczenia zaburzeń OUN |
| JP6875996B2 (ja) | 2015-02-20 | 2021-05-26 | セージ セラピューティクス， インコーポレイテッド | 神経刺激性ステロイド、組成物、およびその使用 |
| JP7049313B2 (ja) | 2016-07-11 | 2022-04-06 | セージ セラピューティクス， インコーポレイテッド | Ｃ１７、ｃ２０、およびｃ２１置換神経刺激性ステロイドおよびそれらの使用方法 |
| ES2992037T3 (es) | 2016-07-11 | 2024-12-05 | Sage Therapeutics Inc | Esteroides neuroactivos sustituidos en C7, C12 y C16 y sus procedimientos de utilización |
| ES2991092T3 (es) * | 2017-12-22 | 2024-12-02 | Sage Therapeutics Inc | Compuestos 19-homo, 3-alfa-hidroxi-esteroides-20-ona para el tratamiento de trastornos del SNC |
| CR20240234A (es) | 2019-05-31 | 2024-07-09 | Sage Therapeutics Inc | ESTEROIDES NEUROACTIVOS Y COMPOSICIONES DE ESTOS (Divisional 2021-629) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE791196A (fr) * | 1971-11-11 | 1973-05-10 | Glaxo Lab Ltd | Nouveaux steroides, leur procede de preparation et leurs applications |
| GB1409239A (en) * | 1971-11-11 | 1975-10-08 | Glaxo Lab Ltd | Process for the preparation of 3alpha-hydroxy-5alpha-steroids |
-
1974
- 1974-08-05 DE DE2438020A patent/DE2438020A1/de not_active Withdrawn
-
1975
- 1975-07-22 CS CS5170A patent/CS175498B2/cs unknown
- 1975-07-22 CS CS215A patent/CS175500B2/cs unknown
- 1975-07-23 IL IL47770A patent/IL47770A/xx unknown
- 1975-07-24 ES ES439720A patent/ES439720A1/es not_active Expired
- 1975-07-29 DK DK344475A patent/DK136369C/da active
- 1975-08-01 CA CA232,730A patent/CA1037027A/en not_active Expired
- 1975-08-01 DD DD187639A patent/DD120192A5/xx unknown
- 1975-08-01 AT AT600475A patent/AT345998B/de not_active IP Right Cessation
- 1975-08-04 FR FR7524225A patent/FR2281123A1/fr not_active Withdrawn
- 1975-08-04 GB GB32477/75A patent/GB1512258A/en not_active Expired
- 1975-08-04 HU HU75SCHE529A patent/HU171684B/hu unknown
- 1975-08-04 SE SE7508777A patent/SE404804B/xx unknown
- 1975-08-05 BE BE158941A patent/BE832124A/xx unknown
- 1975-08-05 CH CH1020975A patent/CH611910A5/xx not_active IP Right Cessation
- 1975-08-05 JP JP50095322A patent/JPS5141347A/ja active Pending
- 1975-08-05 US US05/602,098 patent/US4029777A/en not_active Expired - Lifetime
- 1975-08-05 NL NL7509326A patent/NL7509326A/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DK136369B (da) | 1977-10-03 |
| SE7508777L (sv) | 1976-02-06 |
| FR2281123A1 (fr) | 1976-03-05 |
| DK136369C (da) | 1978-02-27 |
| GB1512258A (en) | 1978-05-24 |
| DD120192A5 (es) | 1976-06-05 |
| CS175500B2 (es) | 1977-05-31 |
| NL7509326A (nl) | 1976-02-09 |
| ATA600475A (de) | 1978-02-15 |
| AU8351575A (en) | 1977-02-03 |
| ES439720A1 (es) | 1977-03-01 |
| CA1037027A (en) | 1978-08-22 |
| JPS5141347A (en) | 1976-04-07 |
| DK344475A (da) | 1976-02-06 |
| US4029777A (en) | 1977-06-14 |
| HU171684B (hu) | 1978-02-28 |
| BE832124A (fr) | 1976-02-05 |
| IL47770A0 (en) | 1975-10-15 |
| SE404804B (sv) | 1978-10-30 |
| IL47770A (en) | 1978-10-31 |
| DE2438020A1 (de) | 1976-02-26 |
| AT345998B (de) | 1978-10-10 |
| CH611910A5 (es) | 1979-06-29 |